|
CS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.632300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.856800E-01 |
| Normal-vs-Stage2 |
1.099530E-03 |
| Normal-vs-Stage3 |
8.363200E-01 |
| Normal-vs-Stage4 |
6.386800E-01 |
| Stage1-vs-Stage2 |
3.260700E-03 |
| Stage1-vs-Stage3 |
4.649200E-01 |
| Stage1-vs-Stage4 |
7.223000E-01 |
| Stage2-vs-Stage3 |
1.615140E-03 |
| Stage2-vs-Stage4 |
3.077700E-03 |
| Stage3-vs-Stage4 |
7.946400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.288400E-01 |
| Normal-vs-AfricanAmerican |
1.009390E-01 |
| Normal-vs-Asian |
6.060400E-01 |
| Caucasian-vs-AfricanAmerican |
2.804000E-01 |
| Caucasian-vs-Asian |
9.525400E-01 |
| AfricanAmerican-vs-Asian |
4.212000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.418210E-01 |
| Normal-vs-Female |
1.081000E-01 |
| Male-vs-Female |
7.396600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.607600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.146800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.838510E-03 |
| Normal-vs-Age(81-100Yrs) |
6.611800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.342800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.390220E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.590200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.137500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.519800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.820270E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.324400E-01 |
| Classical-VS-Follicular |
8.803700E-03 |
| Classical-VS-Other |
1.832040E-01 |
| Classical-VS-Normal |
2.792200E-01 |
| Tall-VS-Follicular |
9.023300E-03 |
| Tall-VS-Other |
3.071000E-01 |
| Tall-VS-Normal |
9.760400E-01 |
| Follicular-VS-Other |
1.344140E-02 |
| Follicular-VS-Normal |
2.884000E-03 |
| Other-VS-Normal |
1.940570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.071800E-02 |
| Normal-vs-N1 |
6.642500E-02 |
| N0-vs-N1 |
4.004000E-04 |
|
|
